Estimation of cholesterol solubilization by a mixed micelle binding model in aqueous tauroursodeoxycholate: Lecithin:cholesterol solutions

Journal of Pharmaceutical Sciences

Volumn 97, Issue 1, 2008, Pages 340-349

  Higuchi, William I ^a   Tzeng, Chinn Shin ^b   Chang, Shyh Jye ^b   Chiang, Huey Jenn ^b   Liu, Chen Lun ^b  

^a UNIVERSITY OF UTAH   (United States)

^b NATIONAL DONG HWA UNIVERSITY   (Taiwan)

Author keywords

Dissolution; Light scattering; Liposomes; Micelle; Solubility

Indexed keywords

LIPOSOME; PHOSPHATIDYLCHOLINE; URSODEOXYCHOLIC ACID;

ARTICLE; DISSOLUTION; GALLSTONE; MATHEMATICAL MODEL; MICELLIZATION; PROTEIN BINDING; SOLUBILITY; SOLUBILIZATION;

EID: 38349165102     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21096     Document Type: Article

References (40)

1. Donovan JM, Carey MC. 1991. Physical-chemical basis of gallstone formation. In: Cooper AD, editor. Pathogenesis and therapy of gallstone disease. New York: Saunders. pp 47-66.
2. Danzinger RG, Hofmann AF, Schoenfield JL, Thistle JL. 1972. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 286:1-8.
3. Hofmann AF. 1984. Medical treatment of cholesterol gallstones by bile desaturating agents. Hepatology 4:199S-208S.
4. Tint SG, Salen G, Colalillo A, Graber D, Verga D, Speck J, Sheffer S. 1982. Ursodeoxycholic acid: A safe and effective agent for dissolving cholesterol gallstone. Ann Intern Med 97:351-356.
5. Stiehl A, Raedsch R, Czygan P, Gotz R, Manner CH, Walker S, Kommerell B. 1980. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid. Gastroenterology 79:1192-1198.
6. Roehrkasse R, Fromm H, Malavolti M, Tunuguntla AK, Ceryak S. 1986. Gallstone dissolution treatment with a combination of chenodeocycholic and ursodeoxycholic acids. Dig Dis Sci 31:1032-1040.
7. Podda M, Zuin M, Battezzati PM, Ghezzi C, de Fazio C, Dioguardi ML. 1989. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: A comparison with ursodeoxycholic acid alone. Gastroenterology 96:222-229.
8. Carey MC, Mazer NA, Benedek GB. 1977. Novel physical-chemical properties of ursodeoxycholic acid (UDCA) and its conjugates: Relative to gallstone dissolution in man. Gastroenterology 72:1036.
9. Carey MC, Ko G. 1979. The importance of total lipid concentration in determining cholesterol solubility in bile and the development of critical tables for calculating "percent cholesterol saturation" with a correction factor for ursodeoxycholate-rich bile. In: Paumgartner G, Stiehl A, Gerok W, editors. Biological effects of bile acids. Lancaster, England: MTP Press. pp 299-308.
10. Lee PH, Higuchi WT, Mazer NA. 1990. Cholesterol monohydrate dissolution rates and solubilities in aqueous taurocholate, taurochenodeoxycholate and tauroursodeoxycholate solutions: A comparative study. J Colloid Interface Sci 137:48-65.
11. Igimi H, Carey MC. 1981. Cholesterol gallstone dissolution in bile: Dissolution kinetics of crystalline (anhydrate and monohydrate) cholesterol with chenodeoxycholate, ursodeoxycholate, and their glycine and taurine conjugates. J Lipid Res 22: 254-270.
12. Lee PH, Higuchi WI, Adachi Y, Mazer NA. 1992. Mechanisms of cholesterol monohydrate dissolution in aqueous taurocholate-, taurochenodeoxycholate-, and tauroursodeoxycholate-lecithin solutions-Correlation between micellar species and dissolution rates. J Colloid Interface Sci 154: 35-50.
13. VonBergmann K, Epple-Gutsfeld M, Leiss O. 1984. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology 87:136-143.
14. Corrigan OI, Su CC, Higuchi WI, Hofmann AF. 1980. Mesophase formation during cholesterol dissolution in ursodeoxycholate-lecithin solutions: New mechanism for gallstone dissolution in humans. J Pharm Sci 69:869-871.
15. Su CC, Park JY, Higuchi WI, Alkan MH, Corrigan OI, Hofmann AF, Danzinger RG. 1981. Mesophase formation during in vitro cholesterol gallstone dissolution: A specific effect of ursodeoxycholic acid. J Pharm Sci 70:713-715.
16. Su CC, Higuchi WI, Gilmore IT, Danzinger RG, Hofmann AF. 1984. Mesophase formation during cholesterol gallstone dissolution in human bile: Effect of bile acid composition. J Pharm Sci 73:1160-1161.
17. Salvioli G, Igimi H, Carey MC. 1983. Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxhcholate-lecithin mixtures: Dissimilar phase equilibria and dissolution mechanisms. J Lipid Res 24:701-720.
18. Somjen GJ, Gilat T. 1983. A non-micellar mode of cholesterol transport in human bile. FEBS Lett 156:265-268.
19. Pattinson NR. 1985. Solubilization of cholesterol in human bile. FEBS Lett 181:339-342.
20. Somjen GJ, Gilat T. 1985. Contribution of vesicular and micellar carriers to cholesterol transport in human bile. J Lipid Res 26:699-704.
21. Kibe A, Dudley MA, Halpern Z, Lynn MP, Breuer AC, Holzbach RT. 1985. Factors affecting cholesterol monohydrate crystal nucleation time in model systems of supersaturated bile. J Lipid Res 26:1102-1111.
22. Pattinson NR, Chapman BA. 1986. Distribution of biliary cholesterol between mixed micelles and non-micelles in relation to fasting and feeding in humans. Gastroenterology 91:697-702.
23. Somjen GJ, Merikovsky Y, Lelkes P, Gilat T. 1986. Cholesterol- phospholipid vesicles in human bile: An ultrastructural study. Biochim Biophys Acta 879:14-21.
24. Lee SP, Park HZ, Madani H, Kaler EW. 1987. Partial characterization of a nonmicellar system of cholesterol solubilization in bile. Am J Physiol 252:G374-383.
25. Jain UK, Higuchi WI, Liu CL, Lee PH, Mazer NA. 1992. Cholesterol (thermodynamic) activity determination in bile salt-lecithin-cholesterol systems and cholesterol-rich liquid crystalline mesophase formation. Pharm Res 9:792-799.
26. Liu CL, Jain UK, Higuchi WI, Mazer NA. 1994. Quasielastic light scattering and cholesterol thermodynamic activity studies of the micelle-to-vesicle transition in conjugated ursodeoxycholate-lecithin- cholesterol solutions. J Colloid Interface Sci 162:437-453.
27. Eckhardt ERM, Heijning BIM, Erpecum KJ, Renooij W, VanBerge-Henegouwen GP. 1998. Quantitation of cholesterol-carrying particles in human gallbladder bile. J Lipid Res 39:594-603.
28. Singleton WS, Gray MS, Brown ML, White JL. 1965. Chromatographically homogeneous lecithin from egg phospholipids. J Am Oil Chem Soc 42:53-56.
29. Carey MC. 1978. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 19:945-955.
30. Carey MC, Montet J, Phillips MC, Armstrong MJ, Mazer NA. 1981. Thermodynamic and molecular basis for dissimilar cholesterol-solubilizing capacities by micellar solutions of bile salts: Cases of sodium chenodeoxycholate and sodium ursodeoxycholate and their glycine and taurine conjugates. Biochemistry 20:3637-3648.
31. Higuchi WI, Arakawa M, Lee PH, Noro S. 1987. Simple micelle-mixed micelle coexistence equilibria for the taurocholate-, taurochenodeoxycholate-, and tauroursodeoxycholate-lecithin systems. J Colloid Interface Sci 119:30-37.
32. Saad HY, Higuchi WI. 1965. Water solubility of cholesterol. J Pharm Sci 54:1205-1206.
33. Mazer NA, Benedek GB, Carey MC. 1980. Quasielastic light scattering studies of aqueous biliary lipid systems: Mixed micelle formation in bile salt-lecithin solution. Biochemistry 19:601-615.
34. Liu CL. 1997. Analysis of cholesterol gallstone therapy based on a model of cholesterol binding to mixed bile salt-lecithin micelles. Chinese Pharm J 49:103-118.
35. Hjelm RP, Thlyagarajan P, Alkan-Onyuksel H. 1992. Organization of phosphatidylcholine and bile salt in rodlike mixed micelles. J Phys Chem 96:8653-8661.
36. Marrink SJ, Mark AE. 2002. Molecular dynamics simulations of mixed micelles modeling human bile. Biochemistry 41:5375-5382.
37. Donovan JM, Carey MC. 1990. Separation and quantitation of cholesterol "carriers" in bile. Hepatology 12:94S-105S.
38. Venneman NG, Kammen MV, Renooij W, VanBerge-Henegouwen GP, Erpecum KJ. 2005. Effects of hydrophobic and hydrophilic bile salts on gallstone growth and dissolution in model biles. Biochim Biophys Acta 1686:209-219.
39. Park YH, Igimi H, Carey MC. 1984. Dissolution of human cholesterol gallstones in simulated chenodeoxycholate-rich and ursodeoxycholate-rich biles. Gastroenterology 87:150-158.
40. Tint GS, Dryszka H, Sanghavi B, Patel G, Patel S, Shefer S, Salen G. 1992. Lithotripsy plus ursodiol is superior to ursodiol alone for cholesterol gallstones. Gastroenterology 102:2042-2049.